Pfizer, Novartis developing MenB vaccines to combat new strain
Recent outbreaks of a strain of meningitis, known as “serogroup B” or “MenB”, on US college campuses have caused both Pfizer and Novartis to develop new vaccines.
Archives for April 8, 2014
Australia launches manufacturing grants to fill biologics ‘gap’
Small-sized Australian biopharma developers will be able to use a GMP cell line contract manufacturing facility operated by Patheon Biologics (formerly DSM Biologics) as a result of a AUS$2m (US$1.8m) grant fund.
Takeda licenses Fleximar-ADC conjugation and linker tech from Mersana
Takeda has licensed a biodegradable polymer and customisable linker platform from Mersana Therapeutics who says the tech offers advantages over other antibody-drug conjugate (ADC) approaches.
Integrity test helps assure no flaws in single-use systems, says ASI
ASI has developed a last-chance confidence test for single-use biomanufacturers looking for assurance there are no flaws in their bioreactor bags.